Mesoblast (NASDAQ: MESO) reported Q2 EPS of ($0.05), versus ($0.29) reported last year. Revenue for the quarter came in at $1.87 million, versus $13.4 million reported last year.

For earnings history and earnings-related data on Mesoblast (MESO) click here.